Latest KFF Health News Stories
With Trump Front of Mind, New Hampshire Voters Cite Abortion and Obamacare as Concerns
New Hampshire’s primary election was dominated by voters’ feelings about Donald Trump. But health care remains a concern — and for Democrats, preserving abortion access is a priority.
Medicare Advantage Is Popular, but Some Beneficiaries Feel Buyer’s Remorse
Medicare Advantage plans are booming — 30.8 million of the 60 million Americans with Medicare are now enrolled in the private plans rather than the traditional government-run program. But a little-known fact: Once you’re in a Medicare Advantage plan, you may not be able to get out. Traditional Medicare usually requires beneficiaries to pay 20 […]
Watch: Older Americans Say They Feel Stuck in Medicare Advantage Plans
You’ve probably seen advertising about Medicare Advantage plans. KFF Health News’ Sarah Jane Tribble explains the pros and cons of this insurance option as enrollment in these plans increases.
Cómo impactaría una segunda presidencia de Trump en la atención de salud
Intentar pronosticar las prioridades de Trump en un segundo mandato es aún más difícil ya que cambia frecuentemente de posición sobre los temas, y lo hace muchas veces.
What Would a Second Trump Presidency Look Like for Health Care?
Health policy during Donald Trump’s tenure was dominated by covid-19 and a failed effort to repeal and replace the Affordable Care Act. His appointments to the Supreme Court led to the end of national abortion rights, and he took steps to increase hospital price transparency and improve care for veterans.
KFF Health News' 'What the Health?': All About the (Government) Funding
With days to go until a large chunk of the federal government runs out of money needed to keep it operating, Congress is still struggling to find a compromise spending plan. Meanwhile, the Supreme Court agreed to hear — this year — a case that pits federal requirements for emergency treatment against state abortion bans. Alice Miranda Ollstein of Politico, Sarah Karlin-Smith of the Pink Sheet, and Tami Luhby of CNN join KFF Health News chief Washington correspondent Julie Rovner to discuss these issues and more. Also this week, Rovner interviews American Medical Association President Jesse Ehrenfeld about the choppy waters facing the nation’s physicians in 2024.
In a Fractious Rerun, GOP Rivals Haley and DeSantis Debate Health Care. Trump Sits It Out.
The fifth debate of the 2024 GOP presidential primary season took place days before Iowa Republicans will caucus to determine their pick for the top of the party’s ticket. The front-runner, former President Donald Trump, once again did not participate.
The AMA Wants a Medicare Cut Reversed – And Lawmakers To Stay Out of Care
Congress is back this week and feverishly working on a bipartisan agreement to fund the government for the rest of the 2024 fiscal year. Ahead of a potential vote, I spoke with Jesse Ehrenfeld, the president of the American Medical Association, the nation’s largest lobby group for doctors, about his organization’s priorities in Washington. Some […]
Adultos mayores se sienten “atrapados” en planes de Medicare Advantage
Al parecer el programa de planes privados para adultos mayores comienza a presentar obstáculos cuando surgen enfermedades.
Older Americans Say They Feel Trapped in Medicare Advantage Plans
As enrollment in private Medicare Advantage plans grows, so do concerns about how well the insurance works, including from those who say they have become trapped in the private plans as their health declines.
KFF Health News' 'What the Health?': 2023 Is a Wrap
2023 was another busy year in health care. As the covid-19 pandemic waned, policymakers looked anew at long-standing obstacles to obtaining and paying for care in the nation’s health care system. Meanwhile, abortion has continued to be an issue in much of the nation, as states respond to the Supreme Court’s 2022 decision overturning the constitutional right to the procedure. This week, Rachel Cohrs of Stat, Sandhya Raman of CQ Roll Call, and Joanne Kenen of Johns Hopkins University and Politico Magazine join KFF Health News chief Washington correspondent Julie Rovner to discuss these issues and wrap up the year in health. Also this week, Rovner interviews KFF Health News’ Jordan Rau about his joint KFF Health News-New York Times series “Dying Broke.”
KFF Health News' 'What the Health?': Democrats See Opportunity in GOP Threats to Repeal Health Law
Sensing that Republicans are walking into a political minefield by threatening once again to repeal the Affordable Care Act, the Biden administration is looking to capitalize by rolling out a series of initiatives aimed at high drug prices and other consequences of “corporate greed in health care.” Meanwhile, the Supreme Court hears a case that could determine when and how much victims of the opioid crisis can collect from Purdue Pharma, the drug company that lied about how addictive its drug, OxyContin, really was. Alice Miranda Ollstein of Politico, Anna Edney of Bloomberg News, and Rachana Pradhan of KFF Health News join KFF Health News chief Washington correspondent Julie Rovner to discuss these issues and more. Also this week, Rovner interviews Dan Weissmann of KFF Health News’ sister podcast, “An Arm and a Leg,” about his investigation into hospitals suing their patients over unpaid bills.
Dodging the Medicare Enrollment Deadline Can Be Costly
As open enrollment ends, many people are tuning out. They could wind up with a surprise next year: higher costs and less access to health care providers.
Desperate Families Search for Affordable Home Care
Facing a severe shortage of aides and high costs, people trying to keep aging loved ones at home often cobble together a patchwork of family and friends to help.
KFF Health News' 'What the Health?': Trump Puts Obamacare Repeal Back on Agenda
Although Republicans have never united behind a replacement for the Affordable Care Act, 2024 GOP presidential front-runner Donald Trump said this week he wants to put the issue back on the national agenda. That delights Democrats, who have won at least two elections partly by defending the now-popular health law. Meanwhile, the Texas Supreme Court takes up a case brought by women who say their pregnancy complications further endangered their health due to the vagueness of Texas’ near-total ban on abortions. Joanne Kenen of Johns Hopkins University and Politico Magazine, Sarah Karlin-Smith of the Pink Sheet, and Victoria Knight of Axios News join KFF Health News chief Washington correspondent Julie Rovner to discuss these issues and more. Also this week, Rovner interviews KFF Health News’ Rachana Pradhan, who reported and wrote the latest “Bill of the Month” feature.
Adultos mayores, detectives contra avisos engañosos de Medicare Advantage
Funcionarios de los Centros de Servicios de Medicare y Medicaid le han pedido a las personas mayores y a otros miembros de la comunidad que sean detectives contra el fraude, denunciando tácticas de venta engañosas al 800-MEDICARE.
Uncle Sam Wants You … to Help Stop Insurers’ Bogus Medicare Advantage Sales Tactics
The Biden administration wants to crack down on deceptive or misleading Medicare Advantage and drug plan sales tactics. It’s counting on beneficiaries to help catch offenders.
Medicare Advantage Increasingly Popular With Seniors — But Not Hospitals and Doctors
Some hospitals and physician groups are rejecting Medicare Advantage plans over payment rates and coverage restrictions, causing turmoil for patients.
Hospitals and Doctors Are Fed up With Medicare Advantage
Medicare Advantage plans are pretty popular with both lawmakers and ordinary Americans — they now enroll about 31 million people, representing just over half of everyone in Medicare, by KFF’s count. But among doctors and hospitals, it’s a different story. Across the country, provider grumbling about claim denials and onerous preapproval requirements by Advantage plans […]
Why Do We Pay For so Much Worthless Health Care?
Medical advances are expensive. Take Wegovy, the wildly successful obesity drug that we learned last week may also reduce the risk of heart disease. If just 10 percent of Medicare beneficiaries start taking the drug, taxpayers could be on the hook for nearly $27 billion a year. So how can the country afford the latest […]
